Clinical Trials Browser

Phase 2 × Interventional × Anorexia × Clear all

NCT07565415 2026-05-04

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

Phase 2 Not yet recruiting

Gastrointestinal

Anorexia, Cachexia, Carcinoma, Hepatocellular, Malnutrition

NCT00488072 2026-01-26

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

Phase 2 Active not recruiting

Anorexia, Sleep Initiation and Maintenance Disorders, Weight Loss

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase 2 Recruiting

Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Phase 2 Terminated

4 enrolled 12 charts

Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT00489307 2025-11-12

Dexamethasone for Symptom Burden in Advanced Cancer Patients

Phase 2 Active not recruiting

132 enrolled 15 charts

Anorexia, Fatigue, Nausea, Pain

NCT05546476 2025-05-31

PROACC-1

Phase 2 Completed

187 enrolled 24 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

NCT03283488 2023-07-07

Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

Phase 2 Completed

Anorexia, Cachexia, Neoplasms

NCT05380479 2022-05-18

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Phase 2 Unknown

Anorexia, Cachexia, Neoplasms

NCT01503346 2020-02-17

TCM

Phase 2 Completed

Anorexia

NCT00558558 2016-05-13

Haelan and Nutrition in Cancer Patients

Phase 2 Terminated

6 enrolled 5 charts

Anorexia, Cachexia, Weight Loss

NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Phase 2 Terminated

Anorexia, Body Weight Changes

NCT01501396 2014-02-03

Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite

Phase 2 Withdrawn

Anorexia

NCT00219817 2013-09-02

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Phase 2 Completed

Anorexia, Cachexia

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

NCT00527319 2013-01-30

VT-122

Phase 2 Completed

37 enrolled 9 charts

Anorexia, Cachexia

NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Phase 2 Unknown

Anorexia, Fatigue, Weight Loss

NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Phase 2 Completed

Classical hematologyGastrointestinal

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

NCT00316563 2010-02-09

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

Phase 2 Completed

Anorexia, Olfaction Disorders, Neoplasms, Taste Disorders

NCT00535015 2008-07-22

Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer

Phase 2 Terminated

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Weight Loss